Marksans Pharma Ltd Annually Results

Gross Sales

2,622.85

2,177.41

1,852.14

1,490.84

1,376.18

Excise Duty

0

0

0

0

0

Net Sales

2,622.85

2,177.41

1,852.14

1,490.84

1,376.18

Other Operating Income

0

0

0

0

0

Other Income

70.38

50.42

59.31

41.85

6.69

Total Income

2,693.22

2,227.83

1,911.45

1,532.69

1,382.88

Total Expenditure

2,094.21

1,718.83

1,512.82

1,231.96

1,036.58

PBIDT

599.01

509

398.63

300.73

346.3

Interest

11.66

11.2

9.13

8.45

7.99

PBDT

587.35

497.8

389.51

292.29

338.32

Depreciation

83.39

74.27

51.85

44.78

36.15

Minority Interest Before NP

0

0

0

0

0

Tax

128.59

113.74

71.23

57.11

66.69

Deferred Tax

-7.24

-5.11

1.1

3.59

-3.07

Reported Profit After Tax

382.62

314.9

265.32

186.81

238.54

Minority Interest After NP

2.04

1.2

-0.99

2.25

0

Net Profit after Minority Interest

380.58

313.7

266.31

184.57

238.54

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

380.58

313.7

266.31

184.57

238.54

EPS (Unit Curr.)

8.4

6.92

6.41

4.51

5.76

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

80

60

50

25

25

Equity

45.32

45.32

45.32

40.93

40.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.83

23.37

21.52

20.17

25.16

PBDTM(%)

22.39

22.86

21.03

19.6

24.58

PATM(%)

14.58

14.46

14.32

12.53

17.33